A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease (AMBAR)
This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2015 by Grifols Biologicals Inc.
Instituto Grifols, S.A.
Grifols Biologicals Inc.
Information provided by (Responsible Party):
Grifols Biologicals Inc. ( Instituto Grifols, S.A. )
First received: March 16, 2012
Last updated: January 14, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||December 2016|
|Estimated Primary Completion Date:||December 2016 (Final data collection date for primary outcome measure)|